Ex Parte Jackson et al - Page 8



          Appeal No. 2005-1438                                                        
          Application No. 10/027,433                                                  

               We are not persuaded by this argument.  As indicated supra,            
          Oku is not limited to employing its antibacterial and anti-fungal           
          composition in the conventional high temperature glazing method.            
          Oku teaches that the antibacterial and anti-fungal glaze                    
          composition can be used with any conventional glaze, inclusive of           
          that described in Deith, and can be affixed to the substrate of a           
          ceramic product via “any conventional [glazing] process,”                   
          inclusive of the sol-gel glazing process described in Deith.  Oku           
          also teaches that its antibacterial and anti-fungal glaze                   
          composition solves the sanitary problem associated with ceramic             
          products, such as the ceramic tiles described in Deith.  Thus,              
          nothing in Oku teaches away from employing its antibacterial and            
          anti-fungal glaze composition in Deith’s sol-gel glazing process            
          used for glazing ceramic products, such as ceramic tiles.  In               
          fact, the recognition of the sanitary problem associated with               
          ceramic tiles, together with the knowledge of the benefits                  
          offered by both the antibacterial and anti-fugal glaze                      
          composition taught by Oku and the sol-gel glazing process taught            
          by Deith, would have led one of ordinary skill in the art to                
          arrive at the claimed subject matter within the meaning of                  
          35 U.S.C. § 103.                                                            

                                          8                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007